Sarepta Therapeutics has followed through on its promise to file for accelerated approval of its gene therapy SRP-9001 for Duchenne muscular dystrophy (DMD), as it aims for a launch in the middle of ...
Severe - Low privileged users can easily escalate privileges and obtain full cluster control via a formerly undisclosed vulnerability in ...
There was an error while loading. Please reload this page. Below we show a list of papers generated by Denario across scientific disciplines. We note that we have not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback